Want to join the conversation?
$LH 2Q15 Call: We expect LabCorp Diagnostics to grow 3.5-5.5% in 2015, after the impact of approx. 70BP of negative currency. This is an increase from our prior guidance of 3-5%. We expect change in Covance drug development net revenue to be in range of minus 1.5 to plus 0.5% vs. full year 2014, after impact of approx. 320BP of negative currency.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.